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ABSTRACT   
Optical-resolution photoacoustic microscopy (OR-PAM) provides superb optical absorption contrast for red blood cells 
(RBCs), which makes it ideal for in vivo microvasculature imaging.  In comparison, optical coherence tomography 
(OCT), widely used for tissue microstructure imaging, provides high optical scattering contrast. The two contrast 
mechanisms are highly complementary. In this work, we combined OR-PAM and OCT into a single, dual-modality 
imaging instrument for in vivo mouse eye imaging.  We demonstrated in vivo dual-modality imaging of the anterior 
segment of mouse eyes with laser pulse energy within the ANSI laser safety standard.   
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INTRODUCTION  
Optical coherence tomography (OCT) [1] has become the mainstream imaging technology in ophthalmology.  OCT has 
high sensitivity in imaging depth-resolved subsurface tissue structures using coherence gating and coherence 
amplification.  Contrast mechanisms such as Doppler contrast, polarization contrast, spectroscopic contrast, and speckle 
contrast are important in many OCT applications.  The above contrast mechanisms are based on optical scattering 
properties.  In ophthalmology, OCT technology does not satisfy all clinical needs.  Only limited functional imaging 
information is provided by the Doppler OCT.  Invasive fluorescein angiography (FA) and indocyanine green 
angiography (ICGA) are still widely used in eye clinics.  In vivo, label-free imaging technologies with endogenous 
contrast are always desirable for replacing the invasive imaging technologies.  The recent development of optical-
resolution photoacoustic microscopy (OR-PAM) [2], which is based on detecting the optical absorption contrast 
mechanism, introduces a novel member into the family of optical diagnosing tomography.  OR-PAM, along with dark-
field acoustic-resolution photoacoustic microscopy (AR-PAM), photoacoustic computed tomography and 
thermoacoustic tomography, promises to have a substantial impact on biomedical applications in the near future [3, 4].  
In fact, PAM and OCT are complementary technologies since they provide different contrasts.  In this work, we 
combined OR-PAM and OCT within a single, dual-modality imaging instrument for in vivo mouse eye imaging.  We 
demonstrated in vivo dual-modality (OCT and OR-PAM) imaging of the anterior segment in mouse eyes with laser pulse 
energy within the ANSI laser safety standard.   
MATERIALS AND METHODS 
Schematic dual-modality OCT/PAM imaging system setup 
The dual-modality OCT/PAM imaging system setup is shown in Figure 1.  The dual-modality imaging probe, which is 
shown as a green dashed box in Figure 1, will be discussed in next section.  The whole system includes a traditional 
Fourier-domain OCT system [5], a 532 nm pulsed laser, one AO card (NI-6713), one A/D card (NI-5124), and the dual-
modality imaging probe.  The AO card was used to generate trigger signals to fire laser pulses and move the 1D stage.  
The PAM signal detected by the ultrasonic transducer was detected by the NI-5124 card.  The pulsed laser has a pulse 
duration of 2 ns.  Its pulse repetition rate was set as 5000.  The pulse energy was set as 60 nJ for in vivo imaging.  
The Fourier-domain OCT system includes a broadband light source (Superlum D890, 150 nm 3dB bandwidth, 
center wavelength 890 nm), an optical isolator, a 20/80 split-ratio 2 by 2 fiber coupler, a reference arm, a sample arm, 
and a spectrometer in the detection arm. The customized spectrometer was used to detect low back-scattered light from 
the sample.  The CCD line-scan camera has 2048 pixels.  The pixel size is 14 µm × 14 µm.  The maximum frame rate of 
Ophthalmic Technologies XX, edited by Fabrice Manns, Per G. Söderberg, Arthur Ho, Proc. of SPIE Vol. 7550, 
75501Q · © 2010 SPIE · CCC code: 1605-7422/10/$18 · doi: 10.1117/12.843041
Proc. of SPIE Vol. 7550  75501Q-1
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 9/18/2018
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
 
  
 
 
CCD-line scan camera is 29,000.  OCT system’s signal-to-noise ratio (SNR) was measured as 100 dB with 750 µw 
sample arm power and 50 µs CCD A-line integration time.  Comparing to the SNR measured at the imaging depth of 50 
µm, a 9 dB of SNR roll-off was observed at the imaging depth of 2 mm.  The dual-modality imaging system was 
operating at 5000 Alines per second, which was limited by the pulse repetition rate of the laser.   
 
Fig. 1. Schematic dual-modality OCT/PAM imaging system setup 
Schematic setup of the OCT/PAM dual-modality imaging probe for ocular anterior segment imaging [6, 7]  
 
Fig. 2. Schematic setup of the OCT/PAM dual-modality imaging probe  
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Figure 2 shows the schematic setup of the dual-modality OCT/PAM imaging probe.  The sample arm light from the 
OCT system was connected to the dual-modality probe through a HI-780 single mode fiber.  The 532 nm pulsed laser 
was connected to the probe with a 460 HP single mode fiber.  A diachronic mirror was used to combine the collimated 
OCT sample arm light and 532 nm PAM excitation laser.  A Galvo mirror, which was located at the front focus of an 
objective (NA 0.1) was used to deflect the laser beams.  A water cube comprising two isosceles right-angle water prisms 
and a glass plate between them was employed for light wave delivery and acoustic wave coupling.  After passing 
through the water cube, the laser beam was focused at least 200 µm below the tissue surface.  Upon the absorption of the 
laser pulse by the tissue, photoacoustic waves were generated.  Thereafter, it was reflected by the glass plate and 
detected by the ultrasonic transducer.  The ultrasonic transducer (GE, 25 MHz bandwidth), having a line focus along the 
optical scan axis, collected photoacoustic signals from the fast optical scan axis (X axis) without being moved 
mechanically.  The whole probe was attached to a one-dimensional mechanical stage, which scanned perpendicularly to 
the fast optical scan axis.  The OCT A-line image and PAM Aline image were acquired sequentially in time.   
Schematic OCT/PAM system software architecture 
MFC Main Thread
MFC View Class's   Message Processing Thread
DAQ
DAP # 0
DAP # 1
DAP # N
C
R
T 
M
em
or
y
Hard Driver
Streaming Buffer
Ring Buffer # 0
Ring Buffer # 1
Ring Buffer # N
DAQ -- Data Acquisition Thread
DAP -- Data Processing Thread  
Fig. 3. Schematic OCT/PAM system software architecture 
Figure 3 shows the schematic OCT/PAM dual-modality imaging system software architecture.  The software was written 
in Visual C ++.  Multiple threads were used for real time data acquisition (DAQ), data processing (DAP) and image 
presentation tasks.  The DAQ thread acquired data from both the frame grabber and the NI-5124 card.  Raw data was 
sent to the streaming buffer for documentation.  Data frames were sent to different DAP threads for real time data 
processing and data presentation.  The number of DAP threads were scalable in software.   
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Imaging procedures 
All experimental animal procedures were carried out in conformity with the laboratory animal protocol approved by the 
School of Medicine Animal Studies Committee of Washington University in St. Louis.  Nude mice (Hsd, Athymic 
Nude-Foxn1NU, Harlan Co.) were anesthetized by intraperitoneal (IP) injection of a cocktail containing Ketamine (100 
mg/kg) and Xylazine (10mg/kg).  A custom-made animal holder was used to restrain the animal. A breathing device (E-
Z Anesthesia, Euthanex Corp.) was employed to maintain the anesthesia status after the IP injection.  The mouse was 
placed under a water tank to maximize the coupled acoustic wave for best ultrasonic detection.   
In order to acquire a 3D image, an imaging area of 4 mm × 4 mm was scanned.  The step size in both lateral directions 
was 5 µm.  The size of 3D PAM data set was 800 × 800 × 200 while the size of 3D OCT data set was 800 × 800 × 2048. 
RESULTS 
 
Fig 3. In vivo, label-free mouse ocular anterior segment imaging in (A) OCT mode (B) PAM mode and (C) dual-modality mode 
Figure 3 shows the in vivo, label-free ocular anterior segment imaging results.  Figure 3A showed only a 3D OCT image 
of the anterior segment of the mouse eye.  Figure 3B showed only a 3D PAM image of the anterior segment of the 
mouse eye.   Combing the contrast in Fig 3A and Fig 3B, Figure 3C showed a dual-modality 3D OCT/PAM image of the 
anterior segment of the mouse eye.  As shown in Figure 3B, PAM has superb contrast to red blood cells in vasculature 
while OCT has good optical scattering contrast in documenting ocular anterior segment structure.  The combination of 
contrast mechanisms of OCT and PAM may be helpful in diagnosing anterior segment eye diseases in the future. 
    
LASER SAFETY CONSIDERATIONS 
The major laser safety concern for the anterior segment of eye imaging is the safety of anterior segment tissue instead of 
retinal tissue [6].  We assume the laser focus is 200 μm below the surface tissue.  The surface illumination area (NA = 
0.1) is 30 μm.  We scanned 4 mm using 800 points.  The step size was 5 μm.  Thus the repetitive pulse number on the 
illumination area was 6.   The repetitive pulse limit can be calculated as the following: 
MPERP = n-0.25 × MPESP = 6-0.25 × 20 mJ/cm2= 12.78 mJ/cm2 
After multiplying the MPERP with surface illumination area, the maximum permissible pulse energy is calculated as 90 
nJ per pulse.  Thus our pulse energy of 60 nJ per pulse is within safety limit. 
 
CONCLUSIONS 
In vivo, real time imaging and visualization of both microvasculature and microstructure simultaneously are desirable 
for many biomedical applications.  We demonstrated in vivo dual-modality (OCT and OR-PAM) imaging of the anterior 
segment in a mouse eye with laser pulse energy within ANSI laser safety standard.  The endogenous contrasts make this 
instrument safer than the conventional fluorescence dye based imaging devices in diagnosing anterior segment eye 
diseases.  
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